BackKeros Therapeutics Overview
Keros Therapeutics Inc

Keros Therapeutics Target Price

Analysts' average 12-month price target for Keros Therapeutics is $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.62

Average Target Price

$20.3375% upside

3 analysts in the last 4 months

High: $23 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Wells FargoBenjamin Burnett$1854.9% upsideOpen
2026-08-04H.C. WainwrightAndrew Fein$2072.1% upsideOpen
2026-08-04Leerink Partners$2397.9% upsideOpen
2024-11-05JefferiesKelly Shi$107820.8% upsideOpen
2024-11-05Truist FinancialSrikripa Devarakonda$100760.6% upsideOpen
2024-09-23GuggenheimVamil Divan$96726.2% upsideOpen
2024-06-18Piper SandlerJoseph Catanzaro$105803.6% upsideOpen
2022-12-13BTIG$105803.6% upsideOpen
2022-07-27BTIGJulian Harrison$80588.5% upsideOpen
2022-05-18Piper SandlerJoseph Catanzaro$120932.7% upsideOpen

Keros Therapeutics (KROS) FAQ

The latest target price for KROS is $20. Investors often review this figure alongside Keros Therapeutics's historical trend and sector peers before judging valuation or financial health.

Keros Therapeutics trades near $11.62 while the consensus target sits at $20 (75.0% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting KROS's target price ($20), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Keros Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.